A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

A new report notes that the amount of belly fat a patient has is a more useful metric for determining obesity than ...

Inactive patients were at a higher risk for inactivity-related comorbid conditions, including obesity and diabetes, as well ...

Michael W. Schwartz UW Medicine Diabetes Institute, explains how the brain can be targeted to treat obesity and diabetes ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- Black people with obesity are less likely to get weight-loss surgery than others.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The Cyprus Association of Liver Patients "Promitheas" launched a new information campaign on Friday, focusing on the risks ...

BROWNSVILLE — It was an unusually cold Saturday morning in the Rio Grande Valley but that didn't stop hundreds of people from ...

This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a ...

NYSE:ALUR) Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity ...